Lawsuit Overview
San Diego, Sept. 13, 2011 (Shareholders Foundation) -- An investor in Caliper Life Sciences Inc. (NASDAQ: CALP) shares filed a lawsuit in effort to stop the proposed takeover of Caliper Life Sciences by PerkinElmer, Inc at $10.50 per share. If you purchased shares of Caliper Life Sciences Inc. (NASDAQ: CALP) prior to the announcement and currently hold those shares, you have certain ...
You must register (for free) or login to view the entire case.